Register for Newsletter

Startup

Bayer launches biotech innovation platform in China
Bayer launches biotech innovation platform in China
DPIIT signs MoU with Pfizer to strengthen India’s healthcare innovation ecosystem
DPIIT signs MoU with Pfizer to strengthen India’s healthcare innovation ecosystem
Healthium and C-CAMP launch innovations program for surgical and medical technologies
Healthium and C-CAMP launch innovations program for surgical and medical technologies
View More

Digitization

Nanyang Biologics, NVIDIA, HPE & Equinix to launch AI drug discovery platform
Nanyang Biologics, NVIDIA, HPE & Equinix to launch AI drug discovery platform
HCHB and element5 form strategic alliance to accelerate the agentic AI movement in post-acute care
HCHB and element5 form strategic alliance to accelerate the agentic AI movement in post-acute care
Lilly launches $1.1 billion TuneLab platform for AI-enabled drug discovery
Lilly launches $1.1 billion TuneLab platform for AI-enabled drug discovery
View More

Latest Stories

AstraZeneca's Saphnelo succeeds in Phase III as self-injectable lupus treatment

Novo Nordisk’s Wegovy delivered 16.6% weight loss

Bayer inaugurates new phytomedicines lab facility

Bayer launches biotech innovation platform in China

Pete Pharma and FABRX announce strategic partnership

Opinion
Metal-free catalysis is transforming future of sustainable pharmaceutical innovation
Metal-free catalysis is transforming future of sustainable pharmaceutical innovation
From Policy to Practice: How India’s Pharmaceutical Industry is Being Shaped by the PLI Scheme – by Vikram Aditya Sehgal, Director – Finance, Centrient India
From Policy to Practice: How India’s Pharmaceutical Industry is Being Shaped by the PLI Scheme – by Vikram Aditya Sehgal, Director – Finance, Centrient India

Interviews
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Dr. R. Ananthanarayanan CEO, Sajjan India
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Dr. Aman Desai Promoter and Whole Time Director, Aether Industries

Packaging